Follow the 바이오프로테크 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 바이오프로테크 has logged 44 insider filings. The latest transaction was disclosed on 5 June 2026 (Sale). Among the most active insiders: 이성제. All data is accessible without an account.
44
Insider Decl.
n/a
Thresholds
n/a
5 ops.
Buy Volume
n/a
39 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
BioProtech is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions for human health and well-being.